10.21 USD
-0.36 (-3.41%)
At close: Jan 30, 2026
10.21 USD
0 (0%)
After Hours: 1/30/2026, 8:00:01 PM
DSGN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While DSGN has a great health rating, there are worries on its profitability. DSGN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- DSGN had negative earnings in the past year.
- DSGN had a negative operating cash flow in the past year.
- In the past 5 years DSGN always reported negative net income.
- DSGN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- DSGN has a better Return On Assets (-31.85%) than 65.33% of its industry peers.
- DSGN has a better Return On Equity (-33.77%) than 73.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.85% | ||
| ROE | -33.77% | ||
| ROIC | N/A |
ROA(3y)-20.51%
ROA(5y)-18.66%
ROE(3y)-21.37%
ROE(5y)-19.56%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- DSGN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, DSGN has more shares outstanding
- DSGN has more shares outstanding than it did 5 years ago.
- DSGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 28.03 indicates that DSGN is not in any danger for bankruptcy at the moment.
- DSGN has a better Altman-Z score (28.03) than 92.19% of its industry peers.
- DSGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 28.03 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- DSGN has a Current Ratio of 18.71. This indicates that DSGN is financially healthy and has no problem in meeting its short term obligations.
- DSGN's Current ratio of 18.71 is amongst the best of the industry. DSGN outperforms 95.43% of its industry peers.
- DSGN has a Quick Ratio of 18.71. This indicates that DSGN is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of DSGN (18.71) is better than 95.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 18.71 | ||
| Quick Ratio | 18.71 |
3. Growth
3.1 Past
- The earnings per share for DSGN have decreased strongly by -40.00% in the last year.
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- DSGN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.84% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-50.91%
EPS Next 2Y-22.56%
EPS Next 3Y-19.55%
EPS Next 5Y-10.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for DSGN. In the last year negative earnings were reported.
- Also next year DSGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as DSGN's earnings are expected to decrease with -19.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.56%
EPS Next 3Y-19.55%
5. Dividend
5.1 Amount
- No dividends for DSGN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DESIGN THERAPEUTICS INC / DSGN FAQ
What is the ChartMill fundamental rating of DESIGN THERAPEUTICS INC (DSGN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to DSGN.
Can you provide the valuation status for DESIGN THERAPEUTICS INC?
ChartMill assigns a valuation rating of 0 / 10 to DESIGN THERAPEUTICS INC (DSGN). This can be considered as Overvalued.
How profitable is DESIGN THERAPEUTICS INC (DSGN) stock?
DESIGN THERAPEUTICS INC (DSGN) has a profitability rating of 1 / 10.
Can you provide the financial health for DSGN stock?
The financial health rating of DESIGN THERAPEUTICS INC (DSGN) is 8 / 10.